Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Technical Guide to Angiotensin I/II (1-5) in RAS Research

    2026-05-22

    Technical Guide to Angiotensin I/II (1-5) in RAS Research

    What This Product Solves

    Angiotensin I/II (1-5) is a biologically active peptide fragment (Asp-Arg-Val-Tyr-Ile) derived from angiotensin I and II, serving as a research-standard tool for modeling the renin-angiotensin system (RAS). Its utility is focused on workflows investigating blood pressure regulation, vasoconstriction, and aldosterone release stimulation in cardiovascular and renal contexts. This reagent enables controlled studies of peptide hormone vasoconstriction mechanisms, supporting research in hypertension and renal function where precise manipulation of RAS intermediates is essential. It is not designed for non-RAS or unrelated peptide signaling applications, as its biochemical activity and solubility profile are tailored for specific assay environments. For a primer on its context in RAS research, see Practical Use of Angiotensin I/II (1-5) in RAS Research.

    Protocol Parameters

    • Solvent Selection: DMSO (≥66.5 mg/mL) or ethanol (≥69.5 mg/mL) | For stock preparation and dilution in peptide assays | Ensures complete dissolution and reproducible dosing | Product information
    • Storage Temperature: -20°C | All applications requiring extended reagent stability | Minimizes degradation and preserves bioactivity during storage | Product information
    • Working Solution Preparation: Dissolve in DMSO or ethanol; dilute further in assay buffer | Compatible with in vitro RAS activity assays | Prevents precipitation and maintains peptide integrity in physiological buffers | Workflow recommendation
    • Concentration Range: Prepare initial stock solutions at ≥10 mM in DMSO/EtOH; dilute as needed for experimental design | Ensures accurate dosing in both acute and chronic peptide exposure models | Supports flexibility in experimental setup | Workflow recommendation
    • Peptide Handling: Avoid repeated freeze-thaw cycles | All experimental setups | Maintains structural and functional stability | Workflow recommendation

    Workflow Setup and QC Checklist

    • Use only DMSO or ethanol to initially dissolve Angiotensin I/II (1-5). Water-based solvents are not recommended due to insolubility.
    • Prepare aliquots of stock solution to minimize freeze-thaw cycles. Store at -20°C immediately after reconstitution.
    • When diluting into assay buffer, ensure final solvent concentration does not exceed assay tolerance (commonly <1% v/v DMSO or ethanol in cell-based assays).
    • Visually inspect solutions for precipitation or turbidity before use in assays. Discard any aliquots showing signs of degradation.
    • Integrate validated controls for RAS pathway activation to benchmark experimental responses.
    • Document lot number, preparation date, and storage conditions in lab records to support reproducibility.
    • For guidance on RAS-specific assay design, see Technical Guide: Angiotensin I/II (1-5) in RAS Research Workflows.

    Common Failure Modes and Fixes

    • Incomplete Dissolution: If undissolved material persists, verify solvent grade and increase mixing time. Ultrasonication may help but avoid excessive heating.
    • Peptide Precipitation in Assay Buffer: Dilute stocks slowly into buffer with constant mixing; if precipitation occurs, reduce initial peptide concentration or use carrier proteins compatible with your assay.
    • Loss of Activity After Storage: Always aliquot stocks to prevent repeated freeze-thaw cycles. If loss of function is suspected, compare to freshly prepared control aliquots.
    • Non-specific Responses in Non-RAS Models: Restrict use to renin-angiotensin system research or closely related blood pressure regulation peptide assays. Do not apply to unrelated signaling pathways.

    Scope and Limitations

    This product is optimized for controlled investigation of the renin-angiotensin system, including blood pressure regulation and aldosterone signaling. It is not validated for use in studies outside cardiovascular or renal mechanisms, nor for modeling peptides unrelated to angiotensin signaling. The specific solubility profile (DMSO and ethanol only) further limits compatibility with aqueous-only workflows. Users should confirm that their experimental aims align with the defined activity and biochemical properties of this Asp-Arg-Val-Tyr-Ile peptide fragment.

    Conclusion

    Angiotensin I/II (1-5) (SKU A1047) is a precise reagent for RAS modeling in cardiovascular and renal research, providing a standardized Asp-Arg-Val-Tyr-Ile peptide for studies on blood pressure regulation and aldosterone release. Adherence to recommended solvent, storage, and handling protocols is critical for reproducibility and data integrity. For detailed product information, refer to Angiotensin I/II (1-5) at APExBIO. Limit use to validated RAS and blood pressure regulation workflows for optimal results.